Carriers of the APOE4 variant, which is associated with disrupted cholesterol homeostasis,119 are at a significantly greater risk for sporadic (i.e. non-familial) Alzheimer’s disease. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.